Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$1.19 - $1.94 $16,660 - $27,160
-14,000 Reduced 7.46%
173,776 $227,000
Q2 2023

Aug 11, 2023

BUY
$0.92 - $2.03 $44,339 - $97,835
48,195 Added 34.53%
187,776 $328,000
Q4 2022

Feb 13, 2023

BUY
$2.5 - $4.44 $7,117 - $12,640
2,847 Added 2.08%
139,581 $417,000
Q3 2022

Nov 14, 2022

BUY
$2.27 - $4.86 $203,494 - $435,674
89,645 Added 190.37%
136,734 $598,000
Q2 2022

Aug 12, 2022

BUY
$3.36 - $4.32 $85,407 - $109,810
25,419 Added 117.3%
47,089 $187,000
Q1 2022

May 13, 2022

BUY
$2.03 - $4.73 $20,015 - $46,637
9,860 Added 83.49%
21,670 $85,000
Q4 2021

Feb 11, 2022

BUY
$4.45 - $9.4 $7,151 - $15,105
1,607 Added 15.75%
11,810 $54,000
Q3 2021

Nov 12, 2021

BUY
$6.6 - $12.75 $67,339 - $130,088
10,203 New
10,203 $71,000

About Miromatrix Medical Inc.


  • Ticker MIRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,899,200
  • Description
  • Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified huma...
More about MIRO
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.